-
NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup
NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup - 2021. In this Table, provisional cases* of notifiable diseases are... -
Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 10 - Seattle
Source for 2012 national data: National Occupant Protection Use Survey (NOPUS), 2012. Source for 2014 national data: National Occupant Protection Use Survey (NOPUS), 2014.... -
COVID-19 Public Therapeutic Locator
NOTE: This dataset is no longer updated as of 1/31/2024. Please use COVID-19 Treatments. Locations of publicly available COVID-19 Therapeutics. Dataset only includes locations... -
HHS COVID-19 Small Area Estimations Survey - Monovalent Booster Audience - Wave 21
The goal of the Monthly Outcome Survey (MOS) Small Area Estimations (SAE) are to generate estimates of the proportions of adults, by county and month, who were in the population... -
NNDSS - TABLE 1I. Cryptosporidiosis to Cyclosporiasis
NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and... -
Access and Use of Telemedicine During COVID-19
The Research and Development Survey (RANDS) is a platform designed for conducting survey question evaluation and statistical research. RANDS is an ongoing series of surveys from... -
NNDSS - Table II. Cryptosporidiosis to Dengue
NNDSS - Table II. Cryptosporidiosis to Dengue - 2016. In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and... -
COVID-19 Test to Treat
NOTE: This dataset is no longer updated as of 1/31/2024. Please use COVID-19 Treatments. Data Information and Disclaimers The locations displayed above have received an order of... -
Claims Reimbursement to Health Care Providers and Facilities for Testing and Treatment of the Uninsured
The COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing and Treatment of the Uninsured Program provides reimbursements on a rolling basis directly... -
NNDSS - Table II. Invasive Pneumococcal Diseases, All Ages
NNDSS - Table II. Invasive Pneumococcal Diseases, All Ages - 2017. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding... -
NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome
NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome – 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S.... -
NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup
NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup - 2020. In this Table, provisional cases* of notifiable diseases are... -
National Artesunate for Severe Malaria Program Artesunate Dosing Data- April to December 2019
This dataset includes deidentified data on patients receiving artesunate through the National Artesunate for Severe Malaria Program from April- December 2019. This dataset... -
HHS COVID-19 Small Area Estimations Survey - Monovalent Booster Audience - Wave 20
The goal of the Monthly Outcome Survey (MOS) Small Area Estimations (SAE) are to generate estimates of the proportions of adults, by county and month, who were in the population... -
NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b
NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b - 2019. In this Table, provisional cases* of notifiable diseases are... -
New Chikungunya Cases Reported in the Americas
Derived from Pan American Health Organization reports: http://www.paho.org/hq/index.php?option=com_topics&view=article&id=343&Itemid=40931